Results 291 to 300 of about 1,058,153 (397)

PDB2: COST-EFFECTIVENESS OF A NEW HUMAN DERMAL REPLACEMENT FOR THE TREATMENT OF DIABETIC FOOT ULCERS: THE CASE OF FRANCE

, 2000
F Parée, B. Allenet, J Possnett, Lucas J. Carr   +3 more
openalex   +1 more source

Associations Between Diabetic Foot Deformity and the Intrinsic Foot Muscles: A Systematic Review. [PDF]

J Foot Ankle Res
Hanna T, Latey P, Ekanayake K, Ribarovski L, McDonald R, Clarke J.   +5 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Trends in drug–drug interaction prevalence and longitudinal associations with health outcomes in the older community‐dwelling population: Findings from The Irish LongituDinal study on Ageing

British Journal of Clinical Pharmacology, EarlyView.
Aims We estimate trends in severe drug–drug interaction (DDI) prevalence and examine longitudinal associations between DDI exposure and health outcomes (emergency department [ED] visits, quality‐of‐life [QoL] and functional decline) over approximately 10‐years in the older community‐dwelling population in Ireland.
John E. Hughes, Caitriona Cahir, Kathleen E. Bennett   +2 more
wiley   +1 more source

Exploring the influence of growth factors in diabetic foot: A comprehensive bibliometric analysis. [PDF]

Medicine (Baltimore)
Shang J, Jin C, Wang F, Zhang Z, Xie L, Zhou Q, Wang Y, Xu X, Zhang S, Li J.   +9 more
europepmc   +1 more source

Why and how do we perform physical examination(s) in clinical trials? A use case of drug intervention trials in type 2 diabetes mellitus

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to determine the purpose and use of physical examination (PE) in phase 3 and 4 drug interventional clinical trials within type 2 diabetes mellitus. Methods A total of 226 clinical trial protocols identified from the ClinicalTrials.gov database were systematically reviewed by five researchers.
Julia Kopanz, Amy Rogers, Lina Pérez‐Breva, Emily Hall, Prashasthi Devaiah, Isla S. Mackenzie, Bart Lagerwaard, Diederick E. Grobbee, Mira G. P. Zuidgeest, on behalf of the Trials@Home consortium   +9 more
wiley   +1 more source

PDB6: EVALUATION OF CLINICAL AND DEMOGRAPHIC FACTORS ASSOCIATED WITH DIABETIC FOOT ULCER TREATMENT COSTS

, 2000
SW Wade, PJ Kadlubek, JM Fastenau, D Gause, J Thomasson, Gol'dberg Ga   +5 more
openalex   +1 more source

From Ulcer to Amputation: A Systematic Review of Prognostic Models for Diabetic Foot Ulcer Amputation. [PDF]

Risk Manag Healthc Policy
Xie XR, Yu MF, Xu R, Liu Y, Zhang J.
europepmc   +1 more source

Cutting edge strategies for diabetic wound care: Nanotechnology, bioengineering, and beyond

BMEMat, EarlyView.
Graphical abstract illustrates the challenges in diabetic wound healing, covering pathophysiology, formulation hurdles, and emerging therapeutic strategies. It highlights the role of hyperglycemia, formulation complexities, and advanced technologies like bioprinting and AI in improving diabetic wound management. Abstract Diabetic wounds affect millions
Usama Ahmad, Wan Nurhidayah Wan Hanaffi, Anas Islam, Aimen Salman, Mohd Muazzam Khan, Faiyaz Shakeel, Qiang Cai, Xiaojun Cai, Quazi T. H. Shubhra   +8 more
wiley   +1 more source

Retrospective analysis of value-driven outcomes of diabetic foot ulcer in a tertiary hospital in Singapore. [PDF]

BMJ Open
Chia ACK, Tan IE, Tan ZN, Yeo WJ, Zhao Y, Yap CJQ, Ang KA, Au MKH, Chong TT.   +8 more
europepmc   +1 more source